This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Johns Hopkins University. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: The Innovations of Benjamin McNeil
Introduction
Benjamin McNeil is an accomplished inventor based in Washington, DC. He has made significant contributions to the field of medical research, particularly in understanding and mitigating pseudo-allergic drug reactions. His work is vital for improving patient safety and drug efficacy.
Latest Patents
McNeil holds a patent for a novel invention titled "MrgprX2/MrgprB2 expressing cell based assay to detect pseudo-allergic drug reactions and to identify blockers to prevent the adverse reactions." This invention relates to cells and methods for detecting compounds that induce a pseudo-allergic-type reaction and methods for reducing the severity of such reactions. He has 1 patent to his name, showcasing his innovative approach to addressing complex medical challenges.
Career Highlights
Currently, McNeil is affiliated with The Johns Hopkins University, where he continues to advance his research. His work at this prestigious institution allows him to collaborate with leading experts in the field and contribute to groundbreaking studies.
Collaborations
One of his notable collaborators is Xinzhong Dong, with whom he has worked on various research projects aimed at enhancing the understanding of drug reactions.
Conclusion
Benjamin McNeil's contributions to the field of medical research through his innovative patent and collaboration with esteemed colleagues highlight his commitment to improving healthcare outcomes. His work is a testament to the importance of innovation in addressing critical medical issues.